Andrew Zupnick

Oncology Drug Development / Clinical Trial Strategy / CRO Executive

Role
Vice President, Oncology Drug Development at Catalyst Clinical Research
Location
Columbus, OH, US
LinkedIn followers
500 followers

About Andrew Zupnick

PhD with ~20 years in the pharmaceutical industry and 25+ years in oncology:Currently applying my scientific background, business and operational knowledge to support drug development at a global contract research organization (CRO). My focus is exclusively in the cancer therapeutic area as a member of the executive team at Catalyst Clinical Research where I head up the Oncology Solution. I liaise between the commercial and operational functions, with a primary focus on driving internal and external growth and innovation.In addition to working on oncology-specific study consulting, planning, feasibility, and implementation, I\'m closely paired with the sales and marketing functions to build and deliver our differentiated message to the biotech market. I train and support global teams to seek new opportunities for the company\'s growth, speak publicly about new trends in oncology, and lead new initiatives to drive innovation for Catalyst. Specialties: clinical development (oncology focus): study design, trial feasibility and timeline modeling, and trial pricing; protocol and clinical development consulting, clinical operations, pipeline and financial analysis, strategic partnerships, market analysis and lead generation, database development, RFP process, proposal development, bid defenses, presentationsCancer Research: PhD in cell and molecular biology, laboratory methods, scientific writing and publication, public presentationMarketing: Website development, programming (HTML, ASP, Access), rebranding initiatives, social network development, print and online advertising, trade shows, event planning

Experience

  1. Vice President, Oncology Drug Development

    Catalyst Clinical Research

    May 2020 — Present · Columbus, OH, US

Education

  • Columbia University

    MS, MPhil, PhD, Cell and Molecular Biology: p53 tumor suppressor regulation

    2000 — 2006

  • Massachusetts Institute of Technology

    BS, Biology; minor in Biomedical Engineering; concentration in music

    1996 — 2000

Skills

  • Clinical Research
  • Market Research
  • Regulatory Affairs
  • Lifesciences
  • Business Development
  • Laboratory
  • Drug Development
  • Cancer
  • Gcp
  • Biopharmaceuticals
  • Life Sciences
  • Event Planning
  • Lead Generation
  • Infectious Diseases
  • Cross-Functional Team Leadership
  • Electronic Data Capture (Edc)
  • Strategic Partnerships
  • Biotechnology
  • New Business Development
  • Pipelining
  • Oncology
  • Business Strategy
  • Financial Analysis
  • CRO Management
  • Edc
  • Therapeutic Areas
  • Ctms
  • Strategy
  • Clinical Trial Enrollment Projections
  • Clinical Monitoring
  • Clinical Trial Management System (Ctms)
  • Clinical Data Management
  • Good Clinical Practice (Gcp)
  • CRO
  • Clinical Trial Feasibility
  • Ich-Gcp
  • Feasibility Studies
  • Molecular Biology
  • Oncology Clinical Research
  • Global Clinical Trial Implementation

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Andrew Zupnick — Vice President, Oncology Drug Development at Catalyst Clinical Research in Columbus, OH, US | Unifers